SLT Holdings’s Kura Oncology KURA Stock Holding History

SLT Holdings’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,750	Closed	-$254K	–	156
2025 Q3	$254K	Buy	+28,750	New	+$205K	0.16%	111

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

SLT Holdings's KURA Position: Q4 2025 in Review

SLT Holdings sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 28,750 shares — an estimated $254K sold.

SLT Holdings first reported a position in KURA in Q3 2025 and held it in 1 quarter. The position peaked at $254K in Q3 2025. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

SLT Holdings reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
SLT Holdings sold 28,750 Kura Oncology shares in Q4 2025, an estimated $254K.
SLT Holdings first reported a position in Kura Oncology in Q3 2025 and held it in 1 quarter.
SLT Holdings's Kura Oncology position peaked at $254K in Q3 2025.
215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on SLT Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.